Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03297775

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
750 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
45 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g. clinical features, genetic variants, and/or biologic markers) between other forms of ILD (e.g. idiopathic pulmonary fibrosis, IPF) and subclinical RA-ILD that places individuals at risk for the development of lung disease.

Conditions

Timeline

Start date
2017-06-22
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2017-09-29
Last updated
2023-11-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03297775. Inclusion in this directory is not an endorsement.